Parallel-group, single and multiple dose interventional study investigating the tolerability and pharmacokinetic properties of Lu AF35700 in healthy young me
Completed
- Conditions
- mental disorder10039628
- Registration Number
- NL-OMON37766
- Lead Sponsor
- undbeck
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 29
Inclusion Criteria
Healthy male
Exclusion Criteria
Clinical significant abnormalities at medical research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Safety and tolerability</p><br>
- Secondary Outcome Measures
Name Time Method <p>Pharmacokinetics</p><br>